Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : QGEN    crawled date : 2021 - 05 - 28    save search
QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
Published: 2021-05-28 (Crawled : 21:00) - biospace.com/
QGEN | $41.59 -0.72% 150K twitter stocktwits trandingview |
Health Technology
 | | O: 0.59% H: 0.91% C: -0.14%
QGEN | $41.59 -0.72% 150K twitter stocktwits trandingview |
Health Technology
 | | O: 0.59% H: 0.91% C: -0.14%
AMGN | News | $273.6 0.02% 370K twitter stocktwits trandingview |
Health Technology
 | | O: 0.38% H: 1.97% C: 0.73%
fda lung cancer cancer fda approval diagnostic
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M twitter stocktwits trandingview |
Consumer Services
CZOO | $11.685 134.17% 7.6M twitter stocktwits trandingview |

BOF | $1.93 64.96% 55M twitter stocktwits trandingview |

AMST | $3.14 57.0% 59M twitter stocktwits trandingview |
Technology Services
TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing
RILY | $30.87 42.13% 7.8M twitter stocktwits trandingview |
Finance
LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

WHLM | $6.61 30.12% 400K twitter stocktwits trandingview |
Commercial Services
MULN | News | $3.53 29.3% 4.8M twitter stocktwits trandingview |
Information
RBBN 4 | $3.26 26.85% 1.2M twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.